Łukasz Durko

648 total citations
17 papers, 225 citations indexed

About

Łukasz Durko is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Łukasz Durko has authored 17 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Łukasz Durko's work include Pancreatic and Hepatic Oncology Research (8 papers), Neuroendocrine Tumor Research Advances (6 papers) and Pancreatitis Pathology and Treatment (6 papers). Łukasz Durko is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Neuroendocrine Tumor Research Advances (6 papers) and Pancreatitis Pathology and Treatment (6 papers). Łukasz Durko collaborates with scholars based in Poland, United States and Australia. Łukasz Durko's co-authors include Ewa Małecka‐Panas, Ewelina Gaszyńska, Małgorzata Godala, Olga Stasikowska‐Kanicka, Małgorzata Wągrowska‐Danilewicz, Piotr Hogendorf, Janusz Strzelczyk, Renata Talar‐Wojnarowska, Marian Danilewicz and Piotr Grzelak and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Cancers.

In The Last Decade

Łukasz Durko

15 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Łukasz Durko Poland	7	123	70	61	50	30	17	225
Titli Nargis India	8	76 0.6×	53 0.8×	66 1.1×	85 1.7×	34 1.1×	15	308
Marilidia Piglionica Italy	9	61 0.5×	67 1.0×	110 1.8×	25 0.5×	39 1.3×	20	249
Marlid Cruz‐Ramos Mexico	8	100 0.8×	23 0.3×	76 1.2×	29 0.6×	15 0.5×	26	247
Ashley J. Williamson United States	11	162 1.3×	81 1.2×	201 3.3×	34 0.7×	32 1.1×	17	381
Kumiko Goto Japan	12	156 1.3×	70 1.0×	54 0.9×	34 0.7×	6 0.2×	17	371
Wen-Shiung Liou Taiwan	7	95 0.8×	49 0.7×	82 1.3×	132 2.6×	10 0.3×	8	316
Jonathan Evans United Kingdom	7	156 1.3×	59 0.8×	109 1.8×	81 1.6×	72 2.4×	12	355
Shengbao Li China	10	104 0.8×	114 1.6×	181 3.0×	29 0.6×	17 0.6×	30	381
Caroline Tizian Germany	6	71 0.6×	107 1.5×	168 2.8×	32 0.6×	47 1.6×	10	422
Nongnit Laytragoon‐Lewin Sweden	11	93 0.8×	37 0.5×	125 2.0×	28 0.6×	10 0.3×	24	385

Countries citing papers authored by Łukasz Durko

Since Specialization

Citations

This map shows the geographic impact of Łukasz Durko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Łukasz Durko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Łukasz Durko more than expected).

Fields of papers citing papers by Łukasz Durko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Łukasz Durko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Łukasz Durko. The network helps show where Łukasz Durko may publish in the future.

Co-authorship network of co-authors of Łukasz Durko

This figure shows the co-authorship network connecting the top 25 collaborators of Łukasz Durko. A scholar is included among the top collaborators of Łukasz Durko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Łukasz Durko. Łukasz Durko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Durko, Łukasz, et al.. (2025). IgG4-related disease - focus on digestive system involvement. Frontiers in Immunology. 16. 1584107–1584107.

Durko, Łukasz, et al.. (2025). New Interleukin-23 Antagonists’ Use in Crohn’s Disease. Pharmaceuticals. 18(4). 447–447.

Durko, Łukasz, et al.. (2025). Changes Connected to Early Chronic Pancreatitis and Early Pancreatic Cancer in Endoscopic Ultrasonography (EUS): Clinical Implications. Cancers. 17(11). 1891–1891. 1 indexed citations

Durko, Łukasz, et al.. (2024). Diagnostics and Management of Pancreatic Cystic Lesions—New Techniques and Guidelines. Journal of Clinical Medicine. 13(16). 4644–4644. 4 indexed citations

Durko, Łukasz, et al.. (2024). Select Endocrine Disorders and Exosomes in Early PDAC Diagnosis. International Journal of Molecular Sciences. 25(22). 12159–12159. 2 indexed citations

Durko, Łukasz, et al.. (2023). CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation. Journal of Clinical Medicine. 12(12). 4050–4050. 1 indexed citations

Durko, Łukasz, et al.. (2023). The Latest Advancements in Diagnostic Role of Endosonography of Pancreatic Lesions. Journal of Clinical Medicine. 12(14). 4630–4630. 11 indexed citations

Godala, Małgorzata, Ewelina Gaszyńska, Łukasz Durko, & Ewa Małecka‐Panas. (2023). Dietary Behaviors and Beliefs in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine. 12(10). 3455–3455. 20 indexed citations

Bąk‐Romaniszyn, Leokadia, Anna S. Świerzko, A. Sokołowska, et al.. (2019). Mannose-binding lectin (MBL) in adult patients with inflammatory bowel disease. Immunobiology. 225(1). 151859–151859. 7 indexed citations

10.

Durko, Łukasz, Olga Stasikowska‐Kanicka, Małgorzata Wągrowska‐Danilewicz, et al.. (2017). Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis. Disease Markers. 2017. 1–7. 27 indexed citations

11.

Durczyński, Adam, Piotr Hogendorf, Dariusz Szymański, et al.. (2015). Insulinoma - Rare, But Important Clinical Problem. Analysis of a Series of 530 Patients Who Underwent Surgical Treatment for the Pancreatic Tumor. Polish Journal of Surgery. 86(11). 505–10. 2 indexed citations

12.

Durko, Łukasz & Ewa Małecka‐Panas. (2014). Lifestyle Modifications and Colorectal Cancer. Current Colorectal Cancer Reports. 10(1). 45–54. 97 indexed citations

13.

Durko, Łukasz, Olga Stasikowska‐Kanicka, Małgorzata Wągrowska‐Danilewicz, Marian Danilewicz, & Ewa Małecka‐Panas. (2013). An analysis of the correlation of clinical, endoscopic and histological classifications in Crohn’s disease. Gastroenterology Review. 6(6). 377–382. 5 indexed citations

14.

Talar‐Wojnarowska, Renata, Łukasz Durko, Grażyna Rydzewska, et al.. (2012). A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid. Pancreatology. 12(5). 417–420. 20 indexed citations

15.

Talar‐Wojnarowska, Renata, Łukasz Durko, Grażyna Rydzewska, et al.. (2012). Pancreatic cyst fluid analysis for differential diagnosis between benign and malignant lesions. Oncology Letters. 5(2). 613–616. 22 indexed citations

16.

Talar‐Wojnarowska, Renata, et al.. (2011). Efficacy and safety of biological treatment in Crohn’s disease: our experience. Gastroenterology Review. 5. 304–309. 2 indexed citations

17.

Rishi, Arun K., Anil Wali, Łukasz Durko, et al.. (2006). EGF receptor-related protein (ERRP) inhibits invasion of colon cancer cells and tubule formation by endothelial cells in vitro.. Anticancer Research. 26(2A). 1029–37. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact